Clinical Trial Update: Study of the Gut Hormone Analogue G3215 in Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for the gut hormone analogue G3215 in adults with diabetes mellitus and obesity; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity

Drugs mentioned

• G3215

Snippet

Sponsor: Imperial College London | Conditions: Diabetes Mellitus, Obesity | Phase 1 | Status: COMPLETED | Results posted: 2020-12-23